We have located links that may give you full text access.
Exploring the Antibacterial Potential of Green-Synthesized MgO and ZnO Nanoparticles from Two Plant Root Extracts.
Nanomaterials 2023 August 27
The green approach-based nanoparticle synthesis is considered a more cost-effective and ecologically responsible method of producing nanoparticles than other standard techniques. A major accomplishment in resolving these issues is the use of nanoparticles for environmental pollution remediation. This article describes a simple method for producing MgO and ZnO nanoparticles (NPs) using aqueous extracts of Zingiber officinale and Glycyrrhiza roots as the stabilizing and reducing agents, respectively. Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and energy-dispersed X-ray (EDX) spectroscopy methods were used to characterize the biologically synthesized metal oxide nanoparticles (MO NPs). The XRD results showed that the mean crystallite sizes of synthesized ZnO and MgO NPs, which have excellent purity, are 12.35 nm and 4.83 nm, respectively. The spherical or elliptical shape of the synthesized NPs was confirmed by the SEM analysis. The antibacterial activity of the synthesized NPs against both Gram-negative and Gram-positive bacteria was thoroughly investigated. With a medium zone of inhibition of 7 to 10 mm, the as-synthesized MgO NPs and ZnO NPs demonstrated moderate antibacterial activity towards various bacterial strains.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app